Genetic polymorphisms associated with endothelial function in nonarteritic anterior ischemic optic neuropathy

Molecular Vision

Volumn 19, Issue , 2013, Pages 213-219

  Sakai, Tsutomu ^a   Shikishima, Keigo ^a   Matsushima, Masato ^a   Tsuneoka, Hiroshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ASPARAGINE; ASPARTIC ACID; CYSTEINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; GLYCINE; ISOLEUCINE; LYSINE; THREONINE;

ADULT; AGED; ANGIOTENSIN CONVERTING ENZYME GENE; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; ARTICLE; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOTHELIN 1 GENE; ENDOTHELIUM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDEL MUTATION; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84873546398     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hayreh SS. (1996) Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations, and management. In: Katz B (ed) Ophthalmology Clinics of North America: Transient Monocular Visual loss. WB Saunders Co, Philadelphia, pp407-412.
2. Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy: a case-control study of potential risk factors. Arch Ophthalmol 1997; 115:1403-7. [PMID: 9366670].
3. Guyer DR, Miller NR, Auer CL, Fine SL. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1985; 103:1136-42. [PMID: 4026642].
4. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 118:766-80. [PMID: 7977604].
5. Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983; 96:478-83. [PMID: 6624829].
6. Lee MS, Grossman D, Arnold AC, Sloan FA. Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients. Ophthalmology 2011; 118:959-63. [PMID: 21439645].
7. Giambene B, Sodi A, Sofi F, Marcucci R, Fedi S, Abbate R, Prisco D, Menchini U. Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study. Graefes Arch Clin Exp Ophthalmol 2009; 247:693-7. [PMID: 19052769].
8. Talks SJ, Chong NH, Gibson JM, Dodson PM. Fibrinogen, cholesterol and smoking as risk factors for nonarteritic anterior ischaemic optic neuropathy. Eye (Lond) 1995; 9:85-8. [PMID: 7713255].
9. Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N, Yassur I, Vidne O, Zivelin A, Gitel S, Davidson J, Ravid B, Seligsohn U. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999; 106:739-42. [PMID: 10201595].
10. Chung SM, Gay CA, McCrary JA III. Nonarteritic ischemic optic neuropathy: the impact of tobacco use. Ophthalmology 1994; 101:779-82. [PMID: 8152775].
11. Ischemic Optic Neuropathy Decompression Trial Study Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996; 114:1366-74. [PMID: 8906027].
12. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117:603-24. [PMID: 8172267].
13. Potarazu SV. Ischemic optic neuropathy: models for mechanism of disease. Clin Neurosci 1997; 4:264-9. [PMID: 9292253].
14. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989; 2:53-4. [PMID: 2567834].
15. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T. Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88:614-8. [PMID: 2189304].
16. Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990; 322:205-[PMID: 2403657].
17. Sakai T, Shikishima K, Matsushima M, Tsuneoka H. Endothelin-1 in ischemic optic neuropathy. Ophthalmology 2008; 115:1262-[PMID: 18598821].
18. Popov AF, Schulz EG, Hinz J, Schmitto JD, Seipelt R, Koziolek MJ, Rosenberger A, Schoendube FA, Müller GA. Impact of endothelin-1 Lys 198Asn polymorphism on coronary artery disease and endrogan damage in hypertensives. Coron Artery Dis 2008; 19:429-34. [PMID: 18923236].
19. Lee J, Cheong SS, Kim J. Association of endothelial-1 gene polymorphisms with variant angina in Korean patients. Clin Chem Lab Med 2008; 46:1575-80. [PMID: 19012521].
20. Kawasaki A, Purvin VA, Burgett RA. Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 1999; 83:1287-90. [PMID: 10535859].
21. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-3. [PMID: 7647779].
22. Schwahn B, Rozen R., Polymorphisms in the methylenetetrahydrofolate reductase gene: Clinical consequences. Am J Pharmacogenomics 2001; 1:189-201. [PMID: 12083967].
23. Gumprecht J, Zychma MJ, Grzeszczak W, Zukowska-Szczechowska E., Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: Risk of chronic renal failure. End-Stage Renal Disease Study Group. Kidney Int 2000; 58:513-9. [PMID: 10916074].
24. Markoula S, Giannopoulos S, Asproudis I, Kostoulas C, Nikas A, Bagli E, Kyritsis AP, Georgiou I. Renin-angiotensin-aldosterone system genes and nonarteritic anterior ischemic optic neuropathy. Mol Vis 2011; 17:1254-60. [PMID: 21633717].
25. Yamada Y, Izawa H, Ichihara S. Takatsu, Ishihara, Hirayama H, Sone T, Tanaka M, Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347:1916-23. [PMID: 12477941].
26. Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJ, Dargie HJ, Arveiler D, Ruidavets JB, Luc G, Evans A, Cambien F. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999; 33:1169-74. [PMID: 10334806].
27. Barden AE, Herbison CE, Beilin LJ, Micheal CA, Walters BN, Van Bockxmeer FM. Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy. J Hypertens 2001; 19:1775-82. [PMID: 11593097].
28. Beck RW, Gamel JW, Willcourt RJ, Berman G. Acute ischemic optic neuropathy in severe preeclampsia. Am J Ophthalmol 1980; 90:342-6. [PMID: 7425050].
29. Lessell S. Nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 1999; 117:386-8. [PMID: 10088818].
30. Gillow JT, Gibson JM, Dodson PM. Hypertension and diabetic retinopathy-what's the story? Br J Ophthalmol 1999; 83:1083-7. [PMID: 10460781].
31. Asai T, Ohkubo T, Katsuya T, Higaki J, Fu Y, Fukuda M, Hozawa A, Matsubara M, Kitaoka H, Tsuji I, Araki T, Satoh H, Hisamichi S, Imai Y, Ogihara T. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 2001; 38:1321-4. [PMID: 11751711].
32. Jin JJ, Nakura J, Wu Z, Yamamoto M, Abe M, Tabara Y, Yamamoto Y, Igase M, Kohara K, Miki T. Association of endothelin-1 gene variant with hypertension. Hypertension 2003; 41:163-7. [PMID: 12511547].
33. Rabineau KM, Treiber FA, Poole J, Ludwig D. Interactive effects of anger expression and ET-1 Lys198Asn polymorphism on vasoconstriction reactivity to behavioral stress. Ann Behav Med 2005; 30:85-9. [PMID: 16097909].
34. Li H, Louey JWC, Choy KW, Liu DT, Chan WM, Chan YM, Fung NS, Fan BJ, Baum L, Chan JC, Lam DS, Pang CP. EDN1Lys198Asn is associated with diabetic retinopathy in type2 diabetes. Mol Vis 2008; 14:1698-704. [PMID: 18806884].
35. Hayreh SS, Jonas JB, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy and tobacco smoking. Ophthalmology 2007; 114:804-9. [PMID: 17398323].
36. Tanabe Y, Kawasaki R, Wang JJ, Wong TY, Mitchell P, Daimon M, Oizumi T, Kato T, Kawata S, Kayama T, Yamashita H. Angotensin-converting enzyme gene and retinal arteriolar narrowing: the Funagata study. J Hum Hypertens 2009; 23:688-793.
37. Matsumoto A, Iwashima Y, Abiko A, Morikawa A, Sekiguchi M, Eto M, Makino I. Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy. Diabetes Res Clin Pract 2000; 50:195-202. [PMID: 11106834].
38. Nikzamir A, Rashidi A, Esteghamati A, Nakhjavani M, Golmohammadi T, Khalilzadeh O. The relationship between ACE gene insertion/deletion polymorphism and diabetic retinopathy in Iranian patients with type 2 diabetes. Ophthalmic Genet 2010; 31:108-13. [PMID: 20565247].
39. Baris N, Akdeniz B, Ozerkan F, Onder RM, Akarca U, Guneri S. The relationship between hypertensive retinopathy and angiotensin converting enzyme gene polymorphism. Cardiovasc Hematol Disord Drug Targets 2006; 6:57-61. [PMID: 16724936].
40. Ferrazzi P, Di Micco P, Quaglia I, Rossi LS, Bellatorre AG, Gaspari G, Rota LL, Lodigiani C. Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion. Thromb J 2005; 3:13-[PMID: 16144556].